Table 1.
Baseline characteristics of studies included in the systematic review and meta-analysis of erectile dysfunction prevalence among patients with diabetes in Ethiopia, 2020.
| Authors (Reference) | Publication year | Study area/region | Study design | Sample size | Instrument | Response rate | Age, y (mean ± SD) | Prevalence |
|---|---|---|---|---|---|---|---|---|
| Seid A et al.17 | 2017 | Tigray | Cross-sectional | 249 | IIEF-5 | 100% | 43.39 ± 14.7 | 69.90% |
| Hurisa AD & Negera GZ16 | 2020 | Oromia | Cross-sectional | 350 | IIEF-5 | 100% | 47.90 ± 12.2 | 60.40% |
| Asefa A et al.15 | 2019 | Oromia | Cross-sectional | 423 | CSFQ-14 | 94% | 41.76 ± 9.00 | 53.30% |
| Tesfaye T et al.18 | 2020 | Amhara | Cross-sectional | 367 | IIEF-5 | 100% | 54.12 ± 16.51 | 53.10% |
| Walle B et al.9 | 2018 | Amhara | Cross-sectional | 422 | IIEF-5 | 100% | 45.70 ± NR | 86% |
| Worku D et al.8 | 2010 | Oromia | Cross-sectional | 192 | NR | 100% | 44.40 ± 15.6 | 6.8% |
IIEF-5: International Index of Erectile Function; NR: not reported; CSFQ-14: 14-item Changes in Sexual Functioning Questionnaire; SD: standard deviation.